BackNuwellis Overview

Nuwellis Profit Margin

Valuation check: NUWE's profit margin is -123.36%, below the Healthcare sector average of 13.89%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-245.20%
66.31% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-123.36%
30.09% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Nuwellis (NUWE) FAQ

Nuwellis (NUWE) currently reports a profit margin of -123.36% as of June 2026. That compares with -176.44% in the prior-year period — up 30.1% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Nuwellis's profit margin history and peer comparisons.

Nuwellis's profit margin increased from -176.44% to -123.36% — a 30.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuwellis's profit margin of -123.36% is lower than the Healthcare sector average of 13.89%. That is roughly 987.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nuwellis's current -123.36% should be judged against Healthcare norms (sector average: 13.89%) and against NUWE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -123.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Nuwellis, and consider following NUWE for alerts when major investors trade the stock.